Generate Biomedicines (GENB)'s 30-day implied volatility (IV30) was 90.4% at the close on November 6, 2026, down from 98.1% the day before, against a 52-week range of 68.4% to 98.1%. Its 20-day historical volatility was 94.0%.
Data as of November 6, 2026.